Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Orbital Neoplasms

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Orbital Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asbach, P; Bertelmann, E; Denecke, T; Erb-Eigner, K; Haas, M; Hamm, B; Lawaczeck, R; Pietsch, H; Ro, SR; Schwenke, C; Taupitz, M1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Orbital Neoplasms

ArticleYear
DCE-MR imaging of orbital lesions: diagnostic performance of the tumor flow residence time τ calculated by a multi-compartmental pharmacokinetic tumor model based on individual factors.
    Acta radiologica (Stockholm, Sweden : 1987), 2019, Volume: 60, Issue:5

    Topics: Contrast Media; Diagnosis, Differential; Female; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Orbit; Orbital Neoplasms; Organometallic Compounds; Prospective Studies; Reproducibility of Results; Time Factors

2019